Cargando…
Predicted Impact of Mass Drug Administration on the Development of Protective Immunity against Schistosoma haematobium
Previous studies suggest that protective immunity against Schistosoma haematobium is primarily stimulated by antigens from dying worms. Praziquantel treatment kills adult worms, boosting antigen exposure and protective antibody levels. Current schistosomiasis control efforts use repeated mass drug a...
Autores principales: | Mitchell, Kate M., Mutapi, Francisca, Mduluza, Takafira, Midzi, Nicholas, Savill, Nicholas J., Woolhouse, Mark E. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117464/ https://www.ncbi.nlm.nih.gov/pubmed/25079601 http://dx.doi.org/10.1371/journal.pntd.0003059 |
Ejemplares similares
-
Regulatory and Activated T Cells in Human Schistosoma haematobium Infections
por: Nausch, Norman, et al.
Publicado: (2011) -
Schistosoma haematobium Treatment in 1–5 Year Old Children: Safety and Efficacy of the Antihelminthic Drug Praziquantel
por: Mutapi, Francisca, et al.
Publicado: (2011) -
Association between Micronutrients (Vitamin A, D, Iron) and Schistosome-Specific Cytokine Responses in Zimbabweans Exposed to Schistosoma haematobium
por: Reilly, Liam, et al.
Publicado: (2012) -
Field evaluation of a new antibody-based diagnostic for Schistosoma haematobium and S. mansoni at the point-of-care in northeast Zimbabwe
por: Nausch, Norman, et al.
Publicado: (2014) -
Comparing parasitological vs serological determination of Schistosoma haematobium infection prevalence in preschool and primary school-aged children: implications for control programmes
por: WAMI, WELCOME M., et al.
Publicado: (2014)